OrthoPediatrics’ (KIDS) Buy Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of OrthoPediatrics (NASDAQ:KIDS) in a research report sent to investors on Friday morning,Benzinga reports. Needham & Company LLC currently has a $42.00 target price on the stock.

A number of other equities research analysts have also weighed in on the stock. Truist Financial lowered their price objective on shares of OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating for the company in a report on Monday, October 14th. JMP Securities restated a “market outperform” rating and set a $50.00 price target on shares of OrthoPediatrics in a research report on Friday, September 13th.

OrthoPediatrics Stock Performance

Shares of NASDAQ:KIDS traded down $1.77 during trading on Friday, hitting $25.72. 367,372 shares of the company were exchanged, compared to its average volume of 135,689. The stock has a 50 day moving average of $27.76 and a 200 day moving average of $29.81. OrthoPediatrics has a 52-week low of $24.02 and a 52-week high of $36.23. The company has a market cap of $622.78 million, a PE ratio of -20.91 and a beta of 1.16. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.90 and a quick ratio of 1.96.

Insider Transactions at OrthoPediatrics

In other OrthoPediatrics news, General Counsel Daniel J. Gerritzen sold 10,000 shares of the company’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $29.30, for a total value of $293,000.00. Following the sale, the general counsel now owns 77,304 shares in the company, valued at approximately $2,265,007.20. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 31.80% of the company’s stock.

Institutional Investors Weigh In On OrthoPediatrics

Several hedge funds have recently added to or reduced their stakes in KIDS. Vanguard Group Inc. lifted its stake in shares of OrthoPediatrics by 1.3% in the first quarter. Vanguard Group Inc. now owns 883,827 shares of the company’s stock worth $25,772,000 after buying an additional 11,100 shares in the last quarter. AWM Investment Company Inc. lifted its position in OrthoPediatrics by 14.6% in the 1st quarter. AWM Investment Company Inc. now owns 487,619 shares of the company’s stock valued at $14,219,000 after acquiring an additional 62,000 shares in the last quarter. Harbor Capital Advisors Inc. boosted its stake in OrthoPediatrics by 268.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 246,860 shares of the company’s stock valued at $6,692,000 after purchasing an additional 179,803 shares during the last quarter. Paradigm Capital Management Inc. NY increased its holdings in shares of OrthoPediatrics by 8.0% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 134,400 shares of the company’s stock worth $3,865,000 after purchasing an additional 10,000 shares in the last quarter. Finally, Mutual of America Capital Management LLC raised its stake in shares of OrthoPediatrics by 195.1% in the third quarter. Mutual of America Capital Management LLC now owns 107,609 shares of the company’s stock worth $2,917,000 after purchasing an additional 71,146 shares during the last quarter. 69.05% of the stock is owned by institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.